Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
TGFβ signaling enacts tumor-suppressive functions in normal cells through promotion of several cell regulatory actions including cell-cycle control and apoptosis. Canonical TGFβ signaling proceeds through phosphorylation of the transcription factor, SMAD3, at the C-terminus of the protein. During on...
Main Authors: | Joseph T. Decker, Jeffrey A. Ma, Lonnie D. Shea, Jacqueline S. Jeruss |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/21/5343 |
Similar Items
-
TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01) -
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
by: Sudha Suriyamurthy, et al.
Published: (2019-05-01) -
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01) -
CCN2 Increases TGF-β Receptor Type II Expression in Vascular Smooth Muscle Cells: Essential Role of CCN2 in the TGF-β Pathway Regulation
by: Antonio Tejera-Muñoz, et al.
Published: (2021-12-01) -
Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)